baber/WOPTO huggingface dataset:
Patent DE-69332700-T2 (DE)
Inventor: KAUFMAN JONATHAN J
IPC: A61B17/56
Filed: 1993-11-08
Granted: 2003-10-16
Abstract: Non-invasive therapeutic treatment and/or quantitative evaluation of bone tissue are performed in vivo, by subjecting bone to an ultrasonic acoustic signal pulse of finite duration, and involving a composite sine-wave signal consisting of plural discrete frequencies that are spaced in the ultrasonic region to approximately 2 MHz; the excitation signal is repeated substantially in the range 1 to 1000 Hz. In a quantitative evaluation, the composite sine-wave signal is supplied to one of two transducers on opposite sides of the bone, and the signal received by the other transducer is processed (a) to sequentially average the most recently received given number of successive signals to obtain an averaged per-pulse signal and (b) to produce a Fourier transform of the averaged per-pulse bone-transmitted signal. In a separate operation not involving the bone, the same transducers are subjected to the same excitation, reception and processing, wherein the transducers are exposed to a medium of known acoustic properties and path length, all to the end of producing a reference Fourier transform which is processed with the Fourier transform of the bone-transmitted signal, to yield an evaluation or measurement. In a therapeutic treatment, the transducer supplied by the composite sine-wave signal is thus supplied for a period or periods of time, and with a magnitude, as may be prescribed by the physician for a given patient.
Patent DE-69406413-T2 (DE)
Inventor: BRAUN EUGENE RALPH
IPC: F16D23/06
Filed: 1994-12-19
Granted: 1998-05-20
Abstract: A baulkring-type synchronizer (18) includes cone clutch friction surfaces (24,48 and 26,50) and jaw clutch teeth (36b,28 and 36c,30) for frictionally synchronizing and positive connecting gears (14,16) to a shaft (12). A plurality of rigid members (72) are drivingly interposed between blocker teeth (44,46) affixed to baulkrings (40,42) and self-energizing ramp surfaces (70a-70d) defined on an outer circumference of a hub 32 affixed to the shaft (12). A shift sleeve (34) is slidably splined to the hub (32) and is moved by an operator shift force (Fo) and an additive force (Fa) provided by the self-energizing ramp surfaces. Both forces (Fo and Fa) react against the blocker teeth to engage the friction surfaces. The self-energizing ramp surfaces may be long enough to assist shift completion as unblocking occurs. The rigid members (72) are mounted with limited relative rotation on the shift sleeve (34) e.g. in circumferential slots (34a). <IMAGE>
Patent DE-69406943-T2 (DE)
Inventor: MARQUEZ VICTOR
IPC: C07D473/18
Filed: 1994-09-23
Granted: 1998-05-07
Abstract: Conformationally locked 4',6'-cyclopropane-fused carbocyclic nucleoside analogues. The compounds are prepared by condensing a cyclopropane-fused carbocyclic allylic alcohol with substituted purine or pyrimidine bases. The condensation products are then modified to produce the adenosine, guanosine, cytidine, thymidine and uracil nucleoside analogues. The compounds are therapeutically useful as antimetabolites, or in the preparation of anti-metabolic agents.
Patent DE-69425734-T2 (DE)
Inventor: KUROME TORU
IPC: A61K38/00
Filed: 1994-12-26
Granted: 2001-04-12
Abstract: Aureobasidins useful as a wide-spectrum antimycotic. They are cyclodepsipeptides composed of one hydroxy acid residue having group A<1>, three amino acid residues having groups C<1>, F<1> and H<1>, four N-methylamino acid residues having groups B<1>, D<1>, G<1> and I<1>, and one cyclic amino acid residue having E<1>. A representative example thereof is one wherein A<1> is CH3CH2CH(CH3)-, B<1> is (CH3)2CH-, C<1> is benzyl, cyclohexylmethyl, p-fluorobenzyl, benzyloxymethyl, benzyloxybenzyl, methoxybenzyl, cyclohexylmethyloxybenzyl, etc., D<1> is methyl, benzyl, hydroxymethyl, etc., E<1> is propylene, F<1> is CH3CH2CH(CH3)-, G<1> is (CH3)2CH-, H<1> is (CH3)2CHCH2-, and I<1> is (CH3)2C(OH)-. They have excellent activities against not only candida but also cryptococcus and aspergillus.
Patent DE-69426732-T2 (DE)
Inventor: JOSHI NAYAN HARSUKHRAI
IPC: C23C26/00
Filed: 1994-03-15
Granted: 2001-06-13
Abstract: A process for applying a metal coating to a non-conductive substrate without employing an electroless coating is provided. To this end the substrate is contacted with an activator and then with a self accelerating and replenishing immersion metal compsn. (A) to obtain a coated substrate. The activator comprises a noble metal/group IVA metal sol. Compsn. A is a soln. contg. (i) soluble metal salt whose metal is more noble than the group IVA metal. (ii) a group IA metal hydroxide and (iii) a complexing agent for which log k = 0.73-21.95 for an ion of the metal of the metal salt, log k being the cumulative formation constant. Also claimed is a compsn. comprising (i), (ii), and (iii) above.
Patent DE-69521037-T2 (DE)
Inventor: LEONARDI AMEDEO
IPC: A61P3/06
Filed: 1995-03-17
Granted: 2001-10-25
Abstract: PCT No. PCT/EP95/01001 Sec. 371 Date Sep. 17, 1996 Sec. 102(e) Date Sep. 17, 1996 PCT Filed Mar. 17, 1995 PCT Pub. No. WO95/25726 PCT Pub. Date Sep. 28, 1995New qunazolinyl-amino derivatives useful as  alpha 1-adrenoreceptor blockers are described. These compounds can be used as therapeutic agents for treating afflictions and diseases related to hyperactivity of the  alpha -adrenergic system, such as, for example, arterial hypertension, prostate benign hyperplasia, high intraocular pressure and hpercholesterolemia. Processes for the preparation of the above said compounds are also described.
Patent DE-69533067-T2 (DE)
Inventor: FUERST R
IPC: A61K48/00
Filed: 1995-10-23
Granted: 2005-05-12
Abstract: Antigens are provided which are derived from the enterically transmitted non-A/non-B viral hepatitis agent, known as hepatitis E virus (HEV). The HEV antigens and in particular, soluble species of the capsid protein encoded by the carboxy terminal region of HEV ORF2, are immunoreactive with sera from individuals infected with HEV. In one embodiment, these antigens may be produced by a baculovirus expression vector and form virus-like particles (VLPs). The antigens are useful as diagnostic reagents in diagnostic methods and kits for determining infection of an individual with HEV. The antigens are also useful in vaccine compositions effective in methods for preventing HEV infection.
Patent DE-69611042-T2 (DE)
Inventor: NAQUI ALI
IPC: C12M1/12
Filed: 1996-09-27
Granted: 2001-05-23
Abstract: A container for growth of a microorganism is provided. The container includes a removable vessel cap that includes a barrier separating the sample from a material capable of disinfecting the sample, thereby preventing contact of the sample and the material for a desired time period. The vessel cap may be used independently in other applications. <IMAGE>
Patent DE-69612261-T2 (DE)
Inventor: DE HAAS GEERT
IPC: A23L1/0522
Filed: 1996-11-27
Granted: 2001-10-31
Abstract: Process for the preparation of a sterilized, bake-stable custards comprising     (a) up to 8 wt% UHT-stable, modified starch;   (b) 0.01-10 wt% proteins, preferably milk proteins; (c) 0.05-6 wt% gelling or non-gelling thickener not being a gelling thickener as defined under (e);   (d) 0.001-5 wt% of a salt, interacting: with gelling gums; (e) 0.1-20 wt% of a gelling thickener, interacting with salt (d); and   (f) conventional ingredients, such as sweeteners, flavours, and colorants   balance up to 100 % : water and optionally other ingredients, and wherein all ingredients are mixed   and the obtained mixture is subjected to a sterilization treatment. Preferably, the treatment is carried out in a surface scraped heat exchanger, a tubular heat exchanger, a plate heat exchanger or an autoclave.
Patent DE-69614703-T2 (DE)
Inventor: MAHY LAURENT
IPC: F16M11/12
Filed: 1996-10-25
Granted: 2002-06-20
Abstract: A device comprising two plates (1, 2) arranged one above the other and joined together via length-adjustable electrically controlled actuators (3, 4) and an upright having a constant length and forming the apices of triangles on said plates. The actuators and the upright are rigidly connected to one of the plates (1), i.e. the lower plate, and connected to the other or upper plate (2) via a hinge assembly which includes a gimbal joint and a pivot shaft (62), each pivot shaft (62) being parallel to the opposite side (7) of the triangle defined on said plate.
Patent DE-69621160-T2 (DE)
Inventor: HOLM ERIK
IPC: B04B15/00
Filed: 1996-12-06
Granted: 2002-11-28
Abstract: An apparatus for centrifuging and furthermore automatically handling a container (10) for separating a component, such as fibrin monomer, from plasma, where the container (10) comprises a cylindrical member (11) with a lower rim as well as a piston member (12) with a tubular piston rod (12) projecting upwardly from the upper end of the cylindrical member (11). The apparatus comprises a supporting turntable (1) with a first gripping member (27) releasably gripping the lower rim of the cylindrical member (11) when the container is placed thereon, the supporting turntable being connected to a first activator (5) for rotating the turntable (1) with the container (10) about the central axis thereof. Furthermore, the apparatus comprises a rotatably journalled piston activating mechanism adapted to activate the piston (12) by way of a second activator (21) and provided with a second gripping member (13) for releasably gripping the piston rod (12). The first gripping member (27) is adapted to automatically enter a locking engagement with the inner side of the cylindrical member (11) independent of the rotating position of the container (10) relative to the supporting turntable (1) and upon activation of a third activator (8) when the container (10) is placed on the supporting turntable (1). The second gripping member (13) is adapted to succeedingly and automatically enter a locking engagement with the piston rod (12) upon activation of a fourth activator (15).
Patent DE-69623414-T2 (DE)
Inventor: SCUERO ALBERTO
IPC: E02B5/02
Filed: 1996-11-20
Granted: 2003-04-30
Abstract: A waterproofing system for hydraulic structures by rigid sheets (14, 15) in synthetic material. Localized points (17, 18) of the surface area of the hydraulic structure to be waterproofed are chosen and prepared for applying of mechanical anchoring means for an impermeable sheathing; the sheathing comprises rigid or semi-rigid sheets (14, 15) in synthetic material, which are mechanically and watertightly connected between each other, laid down on the surface (10, 11) of the hydraulic structure fastening them to the anchoring points (17, 18). The previous steps are repeated till completing the impermeable sheathing of part or of the whole surface area of the hydraulic structure. <IMAGE>
Patent DE-69626287-T2 (DE)
Inventor: KOPELMAN AVI
IPC: A61C19/04
Filed: 1996-07-04
Granted: 2003-11-27
Abstract: PCT No. PCT/IL96/00036 Sec. 371 Date Jan. 20, 1998 Sec. 102(e) Date Jan. 20, 1998 PCT Filed Jul. 4, 1996 PCT Pub. No. WO97/03622 PCT Pub. Date Feb. 6, 1997A method of obtaining a dental image, such as a three-dimensional image of teeth, providing a three-dimensional physical teeth model. The three-dimensional physical teeth model can be either: a negative teeth model that includes a matrix with a plurality of cavities or recesses, each corresponding to a tooth; or a positive teeth model, that includes a matrix with a plurality of projections or bulges, each corresponding to a tooth. The method also includes removing a portion of the model in a controlled, step-wise manner, and in each step acquiring an optical image of the model or of its removed portion, digitizing each of the optical images in order to obtain a plurality of digital images, and compiling the plurality of digital images to obtain a three-dimensional digital dental image.
Patent DE-69634577-T2 (DE)
Inventor: KRITZLER STEVEN
IPC: C11D3/20
Filed: 1996-04-17
Granted: 2006-03-09
Abstract: A non-woven fabric is provided wherein the binder includes at least one phenolic biocide, a water soluble film forming polymer, and at least one surfactant. A method of impregnating a fabric to prevent rot is also provided, which comprises contacting a non-woven fabric with a biocidal preparation containing at least one phenolic biocide, a water soluble film forming polymer, and at least one surfactant.
Patent DE-69634665-T2 (DE)
Inventor: KRAMER L
IPC: A61G7/053
Filed: 1996-08-01
Granted: 2005-10-06
Abstract: A mattress (550) is provided having a generally planar upwardly-facing patient surface (552). The mattress (550) includes a stepped downwardly-facing bottom surface (586) having a perimetral portion (580) extending downwardly from the patient surface (552) a first depth and a central projection (576) extending downwardly from the patient surface (552) a second depth greater than the first depth. The mattress (550) also includes head, seat, thigh, and foot portions (558, 560, 562, 564), at least one of which is inflatable. <IMAGE>
Patent DE-69705848-T2 (DE)
Inventor: FELDMAN MICHAEL R
IPC: G11B7/12
Filed: 1997-09-26
Granted: 2002-04-04
Abstract: An integrated optical head, such as, for a disk drive, preferably includes an optically transparent substrate. The substrate has a diffractive optical element formed on one face and a plurality of electrical contact pads exposed on the other face. A light source is positioned to emit light through the substrate, through the diffractive optical element, and toward data storage media. The light source includes a plurality of electrical contact pads corresponding to the plurality of electrical contact pads exposed on the face of the substrate. An optical detector is positioned to detect light reflected from the data storage media, through the diffractive optical element, and through the substrate. The optical detector includes a plurality of exposed electrical contact pads corresponding to the plurality of electrical contact pads exposed on the face of the substrate. The substrate and the light source and optical detector are passively aligned using solder bumps between pairs of contact pads. A mechanical passive alignment arrangement is also disclosed.
Patent DE-69709905-T2 (DE)
Inventor: GRACE JOHN
IPC: A45D31/00
Filed: 1997-10-30
Granted: 2002-08-22
Abstract: A device for use in training in the treatment of finger or toe nails, comprises an artificial digit (2) having a nail (4) removably mounted thereon. The nail may be attached by a screw (18), a ratchet arrangement, or by embedding it in a resilient layer on the surface of the digit.
Patent DE-69721275-T2 (DE)
Inventor: PERSSON LARS
IPC: E21B15/00
Filed: 1997-08-15
Granted: 2004-02-12
Abstract: Drill rig comprising a carrier (1), a boom (2) and a feed device (3) rotatably connected with the boom by means of a rotation device and intended for a rock drilling machine (4). The rotation device comprises a hydraulic cylinder (5) between the feed device (3) and a first link (8). The first link is in addition with the hydraulic cylinder (5) rotatably connected with the feed device (3) and with a second link (9). The second link is furthermore rotatably connected with the boom (2). By means of the hydraulic cylinder the feed device can be swung about an axis of rotation (10) from a position at least 30 DEG  to one side of a vertical line (12) to a position at least 90 DEG  to the other side of the vertical line.
Patent DE-69721548-T2 (DE)
Inventor: SALFELD G
IPC: A61K31/4178
Filed: 1997-02-10
Granted: 2004-04-01
Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor α (hTNFα) are disclosed. These antibodies have high affinity for hTNFα (e.g., Kd=10−8 M or less), a slow off rate for hTNFα dissociation (e.g., Koff=10−3 sec−1 or less) and neutralize hTNFα activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNFα and for inhibiting hTNFα activity, e.g., in a human subject suffering from a disorder in which hTNFα activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.
Patent DE-69728678-T2 (DE)
Inventor: WULFF TRINE
IPC: A61L15/22
Filed: 1997-07-02
Granted: 2005-04-21
Abstract: A hydrocolloid gel composition, especially a wound gel composition, which comprises: a) a water insoluble, water swellable cross-linked cellulose derivative; b) an alginate; and c) distilled water in a sufficient amount to make up the difference between the amount of ingredients a)+b) and 100% and wherein the gel comprises from 0.05 to 5.00% by weight of alginate, shows better absorption capacity than known gels, accelerates the healing by serving as a slow-release system for active ingredients promoting wound healing.
Patent DE-69731529-T2 (DE)
Inventor: GIBERTONI LUCIO
IPC: A61M16/04
Filed: 1997-04-04
Granted: 2005-12-08
Abstract: A cable particularly for tracheostomy and retrograde-intubation techniques; including in combination an elastic guiding wire (2) constituted by a steel wire (3) arranged inside a flexible spring (4) and a traction-resistant steel cord (10) which is rigidly connected to the steel wire (3).
Patent DE-69733665-T2 (DE)
Inventor: LUBART RACHEL
IPC: A61N5/06
Filed: 1997-11-18
Granted: 2006-05-18
Abstract: A method and device for inducing or promoting growth and proliferation of skin cells or tissue or for controlling bacterial skin infection is described. The skin cells are irradiated with a low-intensity broad spectrum light at a wavelength of between about 340 to 3,000 nm. The increase in rate of cultivated cells is useful for example to obtain skin-like tissue needed for skin grafts or for promoting healing of skin wounds or lesions. Light-induced skin bacteria control is useful for example in the treatment of bacterial infections of the skin.
Patent DE-69737420-T2 (DE)
Inventor: LUQUET FRANCOIS-MARIE
IPC: A61K35/747
Filed: 1997-11-28
Granted: 2007-11-15
Abstract: The present invention concerns a purified strain  Lactobacillus acidophilus  identified as CNCM/I-1492 (hereinafter called L.a. I-1492), the microorganism from this strain, a lactic ferment comprising this strain, a process for making dairy products using this ferment, the dairy products obtained by this process and containing at least 500 million per gram et  Lactobacillus acidophilus  (including the L.a. 1-1492 strain) and where at least 380 million/gram are L.a. I-1492, and the use of the L.a. I-1492 strain as a drug, in particular for reducing the level of cholesterol in the blood of a mammal or for treating infectious diseases comprising colds, sinusitis and urinary infections.
Patent DE-69804281-T2 (DE)
Inventor: HENRIKSEN BENT
IPC: A23L1/30
Filed: 1998-10-22
Granted: 2002-10-24
Abstract: A pharmaceutical formulation comprising organic or inorganic selenium,  beta -carotene and/or vitamin A, ascorbic acid or a salt or ester thereof,  PROPORTIONAL -tocopherol or a derivative thereof, methionine and coenzyme Q10 together with a pharmaceutically acceptable carrier therefor suitable for treating such diseases as primary biliary cirrhosis.
Patent DE-69806919-T2 (DE)
Inventor: MCGUIGAN CHRISTOPHER
IPC: C07H19/02
Filed: 1998-04-27
Granted: 2003-02-27
Abstract: A compound having formula (I), wherein R is selected from the group comprising C5 to C20 alkyl, C5 to C20 cycloalkyl, halogens, aryl and alkylaryl; R' is selected from the group comprising hydrogen, alkyl, cycloalkyl, halogens, amino, alkylamino, dialkylamino, nitro, cyano, alkyoxy, aryloxy, thiol, alkylthiol, arythiol, alkyl; R'' is selected from the group comprising hydrogen, alkyl, cycloalkyl, halogens, alkyloxy, aryloxy and aryl; Q is selected from the group comprising O, S and CY2, where Y may be the same or different and is selected from H, alkyl and halogens; X is selected from the group comprising O, NH, S, N-alkyl, (CH2)n where n is 1 to 10, and CY2 where Y may be the same or different and is selected from hydrogen, alkyl and halogens; Z is selected from the group comprising O, S, NH, and N alkyl; U'' is H and U' is selected from H and CH2T, or U' and U'' are joined so as to form a ring moiety including Q wherein U'-U'' together is respectively selected from the group comprising -CTH-CT'T''- and -CT=CT- and -CT'=CT'-, so as to provide ring moieties selected from the group comprising formula (II) and (III) wherein T is selected from the group comprising OH, H, halogens, O-alkyl, O-acyl, O-aryl, CN, NH2 and N3; T' is selected from the group comprising H and halogens and where more than one T' is present they may be the same or different; T'' is selected from the group comprising H and halogens, and W is selected from the group comprising H, a phosphate group and a pharmacologically acceptable salt, derivative or prodrug thereof shows potent anti-viral activity against, for example, varicella zoster virus and cytomegalovirus.
Patent DE-69813925-T2 (DE)
Inventor: DAWSON PHILLIP
IPC: G05D23/02
Filed: 1998-02-13
Granted: 2004-03-11
Abstract: A control head for a thermostatic valve is disclosed which comprises a housing, within which is contained a sensing element (100). The sensing element (100) has a body and an actuating member, the actuating member being operative to move along an axis (A) with respect to the body in response to change in ambient temperature. There is a carrier (102) within the housing. There is further provided connecting means (42) whereby the housing can be secured to a flow valve (10). The body of the sensing element (100) is disposed on the carrier (102) and the actuating member of the sensing element (100) projects from the body such that it can operate a flow valve (10) to which the control head is attached. A user control (61), which may be constituted by part of the housing, is rotatable about an axis parallel to or coaxial with the operating axis (A) of the sensing element. Such rotation causes liner movement of the carrier (102) parallel to the operating axis but causing substantially no axial movement of the housing with respect to the connecting means (42). <IMAGE>
Patent DE-69818438-T2 (DE)
Inventor: ALEXANDRE PATRICK
IPC: G06T1/00
Filed: 1998-03-25
Granted: 2004-05-06
Abstract: A method for examining the surface of an unwinding strip to detect a surface fault. The method includes forming at least a digital image of the strip having a set of image elements each with an assigned digital value. The digital image is filtered to detect surface defects. The filter digital image is processed to identify the type of surface fault in the strip. Before the digital image processing step, the digital image is segmented into doubtful zones each containing a surface defect with the image processing step being carried out on the doubtful zones.
Patent DE-69912000-T2 (DE)
Inventor: GAASTRA ANDRIES
IPC: B62K3/00
Filed: 1999-07-13
Granted: 2004-09-09
Abstract: A cycle on which the user can assume a comfortable upright position, that has a frame with a mainly vertically directed seat tube and a handlebar with a steering tube that is directly fastened to a front fork. In front of the seat tube there is a seat that can be slid along the seat tube to adjust the height. This construction, with a cycle with an upright position of the user, allows a broad range of adjustment of the seat, making the cycle suitable for users of any size. The upright position of the user can be improved even more by placing the bottom bracket axle of the cycle lower than 10 cm above an imaginary line through the wheel axles of the front and rear wheel, preferably even under this line.